United Kingdom

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

7:00am BST
Change (% chg)

¥2 (+0.11%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Sachiaki Ibe

76 2014 Chairman of the Board, Chief Executive Officer, Representative Director

Mitsuhiro Ibe

46 2014 President, Chief Operating Officer, Representative Director

Hirokazu Endo

64 2016 Vice President, Chief Director of Administration, Director of Human Resources, Director of Legal Affairs, Director

Makoto Kishimoto

64 2014 Managing Director, Chief Director of Production & Logistics

Hiroki Kato

56 2019 Director of Pharmaceutical Sales, Director